CASC
GILD icon

Coppell Advisory Solutions Corp’s Gilead Sciences GILD Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.27M Buy
+30,997
New +$2.38M 0.43% 54
2023
Q1 		$1.56M Buy
19,134
+1,041
+6% +$86.2K 0.51% 46
2022
Q4 		$1.55M Buy
+18,093
New +$1.43M 0.53% 48

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coppell Advisory Solutions Corp's GILD Position: Q1 2024 in Review

Coppell Advisory Solutions Corp opened a new position in Gilead Sciences (GILD) in Q1 2024: 30,997 shares worth $2.27M. The stake represents 0.43% of the portfolio and ranks #54 among its holdings. This is a return to the name: Coppell Advisory Solutions Corp previously reported a position in GILD as recently as Q1 2023.

Coppell Advisory Solutions Corp first reported a position in GILD in Q4 2022 and has held it in 3 quarters since. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Coppell Advisory Solutions Corp held 30,997 shares of Gilead Sciences worth $2.27M as of Q1 2024.
  • Gilead Sciences was a new Coppell Advisory Solutions Corp position in Q1 2024.
  • Gilead Sciences made up 0.43% of Coppell Advisory Solutions Corp's portfolio in Q1 2024, its #54 holding.
  • Coppell Advisory Solutions Corp first reported a position in Gilead Sciences in Q4 2022 and has held it in 3 quarters since.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2024, filed 16 May 2024.